Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.

Nielsen HM, Andersen CL, Westman M, Kristensen LS, Asmar F, Kruse TA, Thomassen M, Larsen TS, Skov V, Hansen LL, Bjerrum OW, Hasselbalch HC, Punj V, Grønbæk K.

Sci Rep. 2018 Nov 20;8(1):17311. doi: 10.1038/s41598-018-35596-w.

2.

The development of multimorbidity during 16 years after diagnosis of type 2 diabetes.

Pouplier S, Olsen MÅ, Willadsen TG, Sandholdt H, Siersma V, Andersen CL, Olivarius NF.

J Comorb. 2018 Sep 24;8(1):2235042X18801658. doi: 10.1177/2235042X18801658. eCollection 2018 Jan-Dec.

3.

Brain Natriuretic Peptide in Plasma as Predictor of All-Cause Mortality in a Large Danish Primary Health Care Population Suspected of Heart Failure.

Hejl JL, Grand MK, Siersma V, Goetze JP, de Fine Olivarius N, Andersen CL, Lind B.

Clin Chem. 2018 Dec;64(12):1723-1731. doi: 10.1373/clinchem.2018.293480. Epub 2018 Oct 15.

PMID:
30323082
4.

Classification and Personalized Prognosis in Myeloproliferative Neoplasms.

Grinfeld J, Nangalia J, Baxter EJ, Wedge DC, Angelopoulos N, Cantrill R, Godfrey AL, Papaemmanuil E, Gundem G, MacLean C, Cook J, O'Neil L, O'Meara S, Teague JW, Butler AP, Massie CE, Williams N, Nice FL, Andersen CL, Hasselbalch HC, Guglielmelli P, McMullin MF, Vannucchi AM, Harrison CN, Gerstung M, Green AR, Campbell PJ.

N Engl J Med. 2018 Oct 11;379(15):1416-1430. doi: 10.1056/NEJMoa1716614.

5.

The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer.

Andersen CL, Boisen MM, Sikora MJ, Ma T, Tseng G, Suryawanshi S, Vlad A, Elishaev E, Edwards RP, Oesterreich S.

Horm Cancer. 2018 Dec;9(6):399-407. doi: 10.1007/s12672-018-0350-9. Epub 2018 Oct 9.

PMID:
30302736
6.

[Eosinophilia].

Bjerrum OW, Fassi DE, Madsen G, Stentoft J, Vestergaard H, Rønnov-Jessen D, Pedersen PT, Pulczynski S, Overgaard UM, Andersen CL.

Ugeskr Laeger. 2018 Sep 10;180(37). pii: V01180032. Danish.

PMID:
30259829
7.

Clarithromycin added to bortezomib-cyclophosphamide-dexamethasone impairs health-related quality of life in multiple myeloma patients.

Nielsen LK, Klausen TW, Jarden M, Frederiksen H, Vangsted AJ, Do T, Kristensen IB, Frølund UC, Andersen CL, Abildgaard N, Gregersen H.

Eur J Haematol. 2018 Sep 19. doi: 10.1111/ejh.13175. [Epub ahead of print]

PMID:
30230047
8.

Contribution of allelic imbalance to colorectal cancer.

Palin K, Pitkänen E, Turunen M, Sahu B, Pihlajamaa P, Kivioja T, Kaasinen E, Välimäki N, Hänninen UA, Cajuso T, Aavikko M, Tuupanen S, Kilpivaara O, van den Berg L, Kondelin J, Tanskanen T, Katainen R, Grau M, Rauanheimo H, Plaketti RM, Taira A, Sulo P, Hartonen T, Dave K, Schmierer B, Botla S, Sokolova M, Vähärautio A, Gladysz K, Ongen H, Dermitzakis E, Bramsen JB, Ørntoft TF, Andersen CL, Ristimäki A, Lepistö A, Renkonen-Sinisalo L, Mecklin JP, Taipale J, Aaltonen LA.

Nat Commun. 2018 Sep 10;9(1):3664. doi: 10.1038/s41467-018-06132-1.

9.

A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma.

Gregersen H, Do T, Kristensen IB, Frølund UC, Andersen NF, Nielsen LK, Andersen CL, Klausen TW, Vangsted AJ, Abildgaard N.

Exp Hematol Oncol. 2018 Aug 13;7:18. doi: 10.1186/s40164-018-0110-0. eCollection 2018.

10.

Interpretation of HbA1c in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory (CopLab) Database.

Borg R, Persson F, Siersma V, Lind B, de Fine Olivarius N, Andersen CL.

Diabet Med. 2018 Dec;35(12):1700-1706. doi: 10.1111/dme.13776. Epub 2018 Aug 20.

PMID:
29985535
11.

Avoidable colorectal cancer cases in Denmark - The impact of red and processed meat.

Lourenço S, Gunge VB, Andersson TM, Andersen CLE, Lund AQ, Køster B, Hansen GL.

Cancer Epidemiol. 2018 Aug;55:1-7. doi: 10.1016/j.canep.2018.04.010. Epub 2018 May 25.

12.

Nanosized carriers based on amphiphilic poly-N-vinyl-2-pyrrolidone for intranuclear drug delivery.

Luss AL, Kulikov PP, Romme SB, Andersen CL, Pennisi CP, Docea AO, Kuskov AN, Velonia K, Mezhuev YO, Shtilman MI, Tsatsakis AM, Gurevich L.

Nanomedicine (Lond). 2018 Apr 1;13(7):703-715. doi: 10.2217/nnm-2017-0311. Epub 2018 Apr 9.

13.

The quest for determining one-electron redox potentials of azulene-1-carbonitriles by calculation.

Ree N, Andersen CL, Kilde MD, Hammerich O, Nielsen MB, Mikkelsen KV.

Phys Chem Chem Phys. 2018 Mar 14;20(11):7438-7446. doi: 10.1039/c7cp08687c.

PMID:
29484319
14.

Subphthalocyanine-radiaannulene scaffold - a multi-electron acceptor and strong chromophore.

Lissau H, Andersen CL, Storm FE, Santella M, Hammerich O, Hansen T, Mikkelsen KV, Nielsen MB.

Chem Commun (Camb). 2018 Mar 13;54(22):2763-2766. doi: 10.1039/c8cc00028j.

PMID:
29480303
15.

Thromboembolism prophylaxis in patients with Philadelphia-negative myeloproliferative neoplasms-Clinical practice among Nordic specialists.

Bjerrum OW, Samuelsson J, Ghanima W, Kauppila M, Andersen CL; Nordic Myeloproliferative Neoplasm Study Group.

Eur J Haematol. 2018 May;100(5):475-478. doi: 10.1111/ejh.13043. Epub 2018 Mar 25.

PMID:
29427461
16.

A Danish national effort of BRCA1/2 variant classification.

Pedersen IS, Schmidt AY, Bertelsen B, Ernst A, Andersen CLT, Kruse T, Rossing M, Thomassen M.

Acta Oncol. 2018 Jan;57(1):159-162. doi: 10.1080/0284186X.2017.1400693. Epub 2017 Nov 23. No abstract available.

PMID:
29168416
17.

A genetically inducible porcine model of intestinal cancer.

Callesen MM, Árnadóttir SS, Lyskjaer I, Ørntoft MW, Høyer S, Dagnaes-Hansen F, Liu Y, Li R, Callesen H, Rasmussen MH, Berthelsen MF, Thomsen MK, Schweiger PJ, Jensen KB, Laurberg S, Ørntoft TF, Elverløv-Jakobsen JE, Andersen CL.

Mol Oncol. 2017 Nov;11(11):1616-1629. doi: 10.1002/1878-0261.12136. Epub 2017 Oct 10.

18.

Direct detection of early-stage cancers using circulating tumor DNA.

Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J, Anagnostou V, Fiksel J, Cristiano S, Papp E, Speir S, Reinert T, Orntoft MW, Woodward BD, Murphy D, Parpart-Li S, Riley D, Nesselbush M, Sengamalay N, Georgiadis A, Li QK, Madsen MR, Mortensen FV, Huiskens J, Punt C, van Grieken N, Fijneman R, Meijer G, Husain H, Scharpf RB, Diaz LA Jr, Jones S, Angiuoli S, Ørntoft T, Nielsen HJ, Andersen CL, Velculescu VE.

Sci Transl Med. 2017 Aug 16;9(403). pii: eaan2415. doi: 10.1126/scitranslmed.aan2415.

PMID:
28814544
19.

Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.

Nielsen HM, Andersen CL, Westman M, Kristensen LS, Asmar F, Kruse TA, Thomassen M, Larsen TS, Skov V, Hansen LL, Bjerrum OW, Hasselbalch HC, Punj V, Grønbæk K.

Sci Rep. 2017 Jul 28;7(1):6774. doi: 10.1038/s41598-017-07057-3. Erratum in: Sci Rep. 2018 Nov 20;8(1):17311.

20.

An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes.

Bekker-Jensen DB, Kelstrup CD, Batth TS, Larsen SC, Haldrup C, Bramsen JB, Sørensen KD, Høyer S, Ørntoft TF, Andersen CL, Nielsen ML, Olsen JV.

Cell Syst. 2017 Jun 28;4(6):587-599.e4. doi: 10.1016/j.cels.2017.05.009. Epub 2017 Jun 7.

21.

Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer.

Schøler LV, Reinert T, Ørntoft MW, Kassentoft CG, Árnadóttir SS, Vang S, Nordentoft I, Knudsen M, Lamy P, Andreasen D, Mortensen FV, Knudsen AR, Stribolt K, Sivesgaard K, Mouritzen P, Nielsen HJ, Laurberg S, Ørntoft TF, Andersen CL.

Clin Cancer Res. 2017 Sep 15;23(18):5437-5445. doi: 10.1158/1078-0432.CCR-17-0510. Epub 2017 Jun 9.

22.

Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA.

Worm Ørntoft MB, Jensen SØ, Hansen TB, Bramsen JB, Andersen CL.

Epigenetics. 2017 Aug;12(8):626-636. doi: 10.1080/15592294.2017.1334024. Epub 2017 May 30.

23.

Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer.

Bramsen JB, Rasmussen MH, Ongen H, Mattesen TB, Ørntoft MW, Árnadóttir SS, Sandoval J, Laguna T, Vang S, Øster B, Lamy P, Madsen MR, Laurberg S, Esteller M, Dermitzakis ET, Ørntoft TF, Andersen CL.

Cell Rep. 2017 May 9;19(6):1268-1280. doi: 10.1016/j.celrep.2017.04.045.

24.

Anemia is present years before myelodysplastic syndrome diagnosis: Results from the pre-diagnostic period.

Hansen JW, Sandholdt H, Siersma V, Ørskov AD, Holmberg S, Bjerrum OW, Hasselbalch HC, Olivarius NF, Grønbaek K, Andersen CL.

Am J Hematol. 2017 Jul;92(7):E130-E132. doi: 10.1002/ajh.24757. Epub 2017 May 26. No abstract available.

25.

A systematic review of health-related quality of life in longitudinal studies of myeloma patients.

Nielsen LK, Jarden M, Andersen CL, Frederiksen H, Abildgaard N.

Eur J Haematol. 2017 Jul;99(1):3-17. doi: 10.1111/ejh.12882. Epub 2017 Apr 25. Review.

PMID:
28322018
26.

A nationwide population-based cross-sectional survey of health-related quality of life in patients with myeloproliferative neoplasms in Denmark (MPNhealthSurvey): survey design and characteristics of respondents and nonrespondents.

Brochmann N, Flachs EM, Christensen AI, Andersen CL, Juel K, Hasselbalch HC, Zwisler AD.

Clin Epidemiol. 2017 Mar 2;9:141-150. doi: 10.2147/CLEP.S117587. eCollection 2017.

27.

The non-coding variant rs1800734 enhances DCLK3 expression through long-range interaction and promotes colorectal cancer progression.

Liu NQ, Ter Huurne M, Nguyen LN, Peng T, Wang SY, Studd JB, Joshi O, Ongen H, Bramsen JB, Yan J, Andersen CL, Taipale J, Dermitzakis ET, Houlston RS, Hubner NC, Stunnenberg HG.

Nat Commun. 2017 Feb 14;8:14418. doi: 10.1038/ncomms14418.

28.

Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens.

Andersen CL, Sikora MJ, Boisen MM, Ma T, Christie A, Tseng G, Park Y, Luthra S, Chandran U, Haluska P, Mantia-Smaldone GM, Odunsi K, McLean K, Lee AV, Elishaev E, Edwards RP, Oesterreich S.

Clin Cancer Res. 2017 Jul 15;23(14):3802-3812. doi: 10.1158/1078-0432.CCR-16-1501. Epub 2017 Jan 10.

29.

Tetraceno[2,1,12,11-opqra]tetracene-extended tetrathiafulvalene - redox-controlled generation of a large PAH core.

Broman SL, Andersen CL, Jousselin-Oba T, Mansø M, Hammerich O, Frigoli M, Nielsen MB.

Org Biomol Chem. 2017 Jan 25;15(4):807-811. doi: 10.1039/c6ob02666d.

PMID:
28054066
30.

SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization.

Damas ND, Marcatti M, Côme C, Christensen LL, Nielsen MM, Baumgartner R, Gylling HM, Maglieri G, Rundsten CF, Seemann SE, Rapin N, Thézenas S, Vang S, Ørntoft T, Andersen CL, Pedersen JS, Lund AH.

Nat Commun. 2016 Dec 22;7:13875. doi: 10.1038/ncomms13875.

31.

The Danish National Chronic Myeloid Neoplasia Registry.

Bak M, Ibfelt EH, Stauffer Larsen T, Rønnov-Jessen D, Pallisgaard N, Madelung A, Udby L, Hasselbalch HC, Bjerrum OW, Andersen CL.

Clin Epidemiol. 2016 Oct 25;8:567-572. eCollection 2016. Review.

32.

Putting a brake on stress signaling: miR-625-3p as a biomarker for choice of therapy in colorectal cancer.

Lyskjær I, Rasmussen MH, Andersen CL.

Epigenomics. 2016 Nov;8(11):1449-1452. Epub 2016 Oct 25. No abstract available.

33.

Corrigendum: A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect.

Lopez-Serra P, Marcilla M, Villanueva A, Ramos-Fernandez A, Palau A, Leal L, Wahi JE, Setien-Baranda F, Szczesna K, Moutinho C, Martinez-Cardus A, Heyn H, Sandoval J, Puertas S, Vidal A, Sanjuan X, Martinez-Balibrea E, Viñals F, Perales JC, Bramsem JB, Ørntoft TF, Andersen CL, Tabernero J, McDermott U, Boxer MB, Vander Heiden MG, Albar JP, Esteller M.

Nat Commun. 2016 Nov 2;7:13467. doi: 10.1038/ncomms13467. No abstract available.

34.

miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer.

Ostenfeld MS, Jensen SG, Jeppesen DK, Christensen LL, Thorsen SB, Stenvang J, Hvam ML, Thomsen A, Mouritzen P, Rasmussen MH, Nielsen HJ, Ørntoft TF, Andersen CL.

J Extracell Vesicles. 2016 Aug 29;5:31488. doi: 10.3402/jev.v5.31488. eCollection 2016.

35.

Synthesis and Single-Molecule Conductances of Neutral and Cationic Indenofluorene-Extended Tetrathiafulvalenes: Kondo Effect Molecules.

Mansø M, Koole M, Mulder M, Olavarria-Contreras IJ, Andersen CL, Jevric M, Broman SL, Kadziola A, Hammerich O, van der Zant HS, Nielsen MB.

J Org Chem. 2016 Sep 16;81(18):8406-14. doi: 10.1021/acs.joc.6b01579. Epub 2016 Sep 1.

36.

miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.

Rasmussen MH, Lyskjær I, Jersie-Christensen RR, Tarpgaard LS, Primdal-Bengtson B, Nielsen MM, Pedersen JS, Hansen TP, Hansen F, Olsen JV, Pfeiffer P, Ørntoft TF, Andersen CL.

Nat Commun. 2016 Aug 16;7:12436. doi: 10.1038/ncomms12436.

37.

SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism.

Christensen LL, True K, Hamilton MP, Nielsen MM, Damas ND, Damgaard CK, Ongen H, Dermitzakis E, Bramsen JB, Pedersen JS, Lund AH, Vang S, Stribolt K, Madsen MR, Laurberg S, McGuire SE, Ørntoft TF, Andersen CL.

Mol Oncol. 2016 Oct;10(8):1266-82. doi: 10.1016/j.molonc.2016.06.003. Epub 2016 Jun 26.

38.

Multistate Switches: Ruthenium Alkynyl-Dihydroazulene/Vinylheptafulvene Conjugates.

Vlasceanu A, Andersen CL, Parker CR, Hammerich O, Morsing TJ, Jevric M, Lindbaek Broman S, Kadziola A, Nielsen MB.

Chemistry. 2016 May 23;22(22):7514-23. doi: 10.1002/chem.201600178. Epub 2016 Apr 26.

PMID:
27114110
39.

High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome.

Delgado E, Boisen MM, Laskey R, Chen R, Song C, Sallit J, Yochum ZA, Andersen CL, Sikora MJ, Wagner J, Safe S, Elishaev E, Lee A, Edwards RP, Haluska P, Tseng G, Schurdak M, Oesterreich S.

Gynecol Oncol. 2016 May;141(2):348-356. doi: 10.1016/j.ygyno.2016.02.030. Epub 2016 Mar 11.

40.

Prevalence and clinical significance of neutropenia discovered in routine complete blood cell counts: a longitudinal study.

Andersen CL, Tesfa D, Siersma VD, Sandholdt H, Hasselbalch H, Bjerrum OW, Felding P, Lind B, Olivarius Nde F, Palmblad J.

J Intern Med. 2016 Jun;279(6):566-75. doi: 10.1111/joim.12467. Epub 2016 Jan 21.

41.

Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.

Ørntoft MB, Nielsen HJ, Ørntoft TF, Andersen CL; Danish Study Group on Early Detection of Colorectal Cancer.

BMC Cancer. 2015 Oct 29;15:819. doi: 10.1186/s12885-015-1832-6.

42.

Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome.

Andersen CL, Nielsen HM, Kristensen LS, Søgaard A, Vikeså J, Jønson L, Nielsen FC, Hasselbalch H, Bjerrum OW, Punj V, Grønbæk K.

Oncotarget. 2015 Dec 1;6(38):40588-97. doi: 10.18632/oncotarget.5845.

43.

Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer?

Andersen CL, Eskelund CW, Siersma VD, Felding P, Lind B, Palmblad J, Bjerrum OW, Friis S, Hasselbalch HC, de Fine Olivarius N.

Gynecol Oncol. 2015 Nov;139(2):312-8. doi: 10.1016/j.ygyno.2015.09.017. Epub 2015 Sep 25. No abstract available.

PMID:
26407478
44.

A new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms.

Brochmann N, Zwisler AD, Kjerholt M, Flachs EM, Hasselbalch HC, Andersen CL.

Qual Life Res. 2016 Apr;25(4):835-46. doi: 10.1007/s11136-015-1125-1. Epub 2015 Sep 11.

PMID:
26358064
45.

Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challenges.

Boisen MM, Andersen CL, Sreekumar S, Stern AM, Oesterreich S.

Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:322-33. doi: 10.1016/j.mce.2015.04.035. Epub 2015 Aug 11.

PMID:
26276546
46.

The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer.

Lin X, Stenvang J, Rasmussen MH, Zhu S, Jensen NF, Tarpgaard LS, Yang G, Belling K, Andersen CL, Li J, Bolund L, Brünner N.

BMC Genomics. 2015 May 22;16:404. doi: 10.1186/s12864-015-1552-y.

47.

[Status and perspectives on chronic myeloproliferative neoplasm treatment].

Ocias LF, Holmström MO, Riley CH, Andersen CL, Rønnov-Jessen D, Starklint J, Frederiksen M, Steffensen MS, Bjerrum OW, Farmer S, Mourits-Andersen T, Hasselbalch HC, Larsen TS.

Ugeskr Laeger. 2015 May 4;177(19). pii: V12140652. Review. Danish.

PMID:
25967090
48.

3'-UTR poly(T/U) repeat of EWSR1 is altered in microsatellite unstable colorectal cancer with nearly perfect sensitivity.

Kondelin J, Tuupanen S, Gylfe AE, Aavikko M, Renkonen-Sinisalo L, Järvinen H, Böhm J, Mecklin JP, Andersen CL, Vahteristo P, Pitkänen E, Aaltonen LA.

Fam Cancer. 2015 Sep;14(3):449-53. doi: 10.1007/s10689-015-9804-1.

PMID:
25930744
49.

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.

Jensen NF, Stenvang J, Beck MK, Hanáková B, Belling KC, Do KN, Viuff B, Nygård SB, Gupta R, Rasmussen MH, Tarpgaard LS, Hansen TP, Budinská E, Pfeiffer P, Bosman F, Tejpar S, Roth A, Delorenzi M, Andersen CL, Rømer MU, Brünner N, Moreira JM.

Mol Oncol. 2015 Jun;9(6):1169-85. doi: 10.1016/j.molonc.2015.02.008. Epub 2015 Feb 24.

50.

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

Reinert T, Schøler LV, Thomsen R, Tobiasen H, Vang S, Nordentoft I, Lamy P, Kannerup AS, Mortensen FV, Stribolt K, Hamilton-Dutoit S, Nielsen HJ, Laurberg S, Pallisgaard N, Pedersen JS, Ørntoft TF, Andersen CL.

Gut. 2016 Apr;65(4):625-34. doi: 10.1136/gutjnl-2014-308859. Epub 2015 Feb 4.

PMID:
25654990

Supplemental Content

Loading ...
Support Center